These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10779668)

  • 1. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
    Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
    Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
    Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
    Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.
    Lawand NB; Lu Y; Westlund KN
    Pain; 1999 Mar; 80(1-2):291-9. PubMed ID: 10204742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
    Bannon AW; Decker MW; Holladay MW; Curzon P; Donnelly-Roberts D; Puttfarcken PS; Bitner RS; Diaz A; Dickenson AH; Porsolt RD; Williams M; Arneric SP
    Science; 1998 Jan; 279(5347):77-81. PubMed ID: 9417028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.
    Decker MW; Curzon P; Holladay MW; Nikkel AL; Bitner RS; Bannon AW; Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Williams M; Arneric SP
    J Physiol Paris; 1998; 92(3-4):221-4. PubMed ID: 9789812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
    Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
    Caban AJ; Hama AT; Lee JW; Sagen J
    Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.
    Damaj MI; Martin BR
    Eur J Pharmacol; 1996 Apr; 300(1-2):51-7. PubMed ID: 8741164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.
    Decker MW; Bannon AW; Buckley MJ; Kim DJ; Holladay MW; Ryther KB; Lin NH; Wasicak JT; Williams M; Arneric SP
    Eur J Pharmacol; 1998 Apr; 346(1):23-33. PubMed ID: 9617748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
    Rashid MH; Ueda H
    Brain Res; 2002 Oct; 953(1-2):53-62. PubMed ID: 12384238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
    Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
    J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epibatidine and pain.
    Traynor JR
    Br J Anaesth; 1998 Jul; 81(1):69-76. PubMed ID: 9771274
    [No Abstract]   [Full Text] [Related]  

  • 19. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
    Kommalage M; Höglund AU
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
    Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
    Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.